Background Systemic Inflammatory Response Syndrome (SIRS) and sepsis remain leading causes of death. Despite many similarities, the two entities are very distinct clinically and immunologically. T-Lymphocytes play a key pivotal role in the pathogenesis and ultimately outcome following both SIRS and sepsis. Integrins are essential in the trafficking and migration of lymphocytes. They also serve vital roles in efficient wound healing and clearance of infections. Here, we investigate whether integrin expression, specifically b1 (CD29) and b2 (CD18), are disrupted in SIRS and sepsis, and assess differences in integrin expression between these two critically ill clinical categories. Methods T-Lymphocytes were isolated from whole blood collected from ICU patients exhibiting SIRS or sepsis. Samples were analyzed for CD18 (b2) and CD29 (b1) on CD3
Introduction
The Systemic Inflammatory Response Syndrome (SIRS) is the inflammatory and immune response to injury and traumatic insult, whereas Sepsis is defined as the systemic inflammatory response to severe microbial infection. The physiological derangement associated with both SIRS and sepsis continues to be leading causes of death among intensive care unit patients with mortality rates continuing to be reported as high as 40-50% [1, 2] . In both SIRS and sepsis, the inflammatory and immune systems appear dysfunctional [3] [4] [5] [6] . This can ultimately cause tissue damage leading to multiple organ failure and death. However, despite many clinical similarities between these two entities, they are immunologically very different conditions [4] .
Within the immune response, it has been shown that T-lymphocytes, including their sub-populations, play key roles in the modulation and survival from both SIRS and sepsis in both murine models and humans [3, [7] [8] [9] [10] . Sepsis has been noted to induce significant lymphocyte dysfunctionality, often noted to be an immunoparalysis, and CD3
? -T-lymphocytes are essential to recovery from sepsis [4] . The immune dysfunction induced in both SIRS and sepsis is thought to lead to patients being at risk for the development of secondary infections, prolonged end-organ dysfunction and ultimately death. We have previously demonstrated that an inappropriate lymphocyte response to traumatic injury (SIRS) in humans is associated with increased mortality [11] . As part of their role in coordinating the inflammatory and/or immune response foreign pathogenic challenge, lymphocytes need to be able to competently migrate and traffic to and from the sites of injury and infection [12] . We have demonstrated that in abdominal sepsis, a failure of lymphocyte sub-populations to migrate led to significant alterations in the innate immune response the infection [13] .
Integrins are known to play a key role in regulating the immune system [14] [15] [16] . They are responsible for efficient migration of, among other cells, lymphocytes from the lymph nodes to the site of wound or infection [17, 18] . Among the integrins expressed upon T-lymphocytes, Integrins b1 and b2 are involved in lymphocyte functions, such as mediating T-cell interactions with other cells as well as modulating intra-cellular signaling. Integrins b1 and b2 also play prominent roles in T-cell migration to peripheral nodes and inflammatory sites, antigen presentation, and cytotoxic killing [16, [19] [20] [21] . The b2 integrin plays a critical role in the leukocyte response to inflammatory states, an importance underscored by the roles in diverse states such from embryogenesis to wound healing. b1 integrins are involved in lymphocyte adhesion, proliferation, and migration, and often serves a co-stimulatory role in inflammatory conditions.
Much of the work on T-cell integrins relates to their function in murine models, healthy humans, or patients with chronic medical conditions [14, [22] [23] [24] . There is a paucity of data addressing the effect of critical illness upon human peripheral blood T-lymphocyte integrin expression and no data regarding differences in expression between the sterile inflammatory state of SIRS compared with the microbiologically driven condition of sepsis in humans. Given the key role of lymphocyte dysfunction in outcomes from SIRS and sepsis, we postulate that the generalization of the inflammatory response in tissue destruction (SIRS) would require less active directed migration of lymphocytes when compared to infectious processes (sepsis) which would mandate a more directed migration of lymphocytes to the site of infection, thereby inducing an alteration of integrin expression between these two patient populations. We undertook this analysis of integrin expression on T-lymphocytes derived from SIRS versus septic critically ill surgical patients.
Methods

Patients
Patients admitted to the surgical or trauma intensive care unit of tertiary care facility were prospectively enrolled. The diagnosis of SIRS was assigned following the parameters defined by the American College of Chest Physicians/Society of Critical Care Medicine. Sepsis was defined as patients with SIRS and a source of infection, requiring Intensive Care Unit (ICU) care. Data were collected to ascertain presence and degree of SIRS at the time of the blood draw and the source of sepsis. Blood draws were undertaken within 24 h of identification of either SIRS or sepsis. In addition, clinical data were collected to calculate an APACHE II score. In patients with sepsis, charts were reviewed to assess the source of the sepsis, and we operationally divided patients into either abdominal or non-abdominal sepsis. To serve as a control, we collected blood from healthy volunteers. Inhospital mortality was also assessed for each patient. This study was executed under the approval of the Institutional review board of Rhode Island Hospital.
Antibody staining
Peripheral blood lymphocytes were collected, erthocytes lysed, and isolated from whole blood samples as previously described by us and others [3] . In brief, CD18 and CD29 expressions were assessed on CD3 ? T cells through flow cytometry. The monoclonal antibodies used for staining were allophycocyanin (APC) anti-CD3 (clone UCHT1, Beckman Coulter) and phycoerythrin (PE) conjugated anti-CD18 (clone 6.7, BD Pharmingen) or PE-conjugated anti-CD29 (clone HUTS21, BD Pharmingen). Antibody optimization for staining was established according to manufacturers' recommendations. 100 ll of whole blood samples were stained in a 5 ml disposal conical with APC-conjugated anti-CD3 (clone UCHT1) and PE-conjugated antiCD18 (clone 6.7) or PE-conjugated antiCD29 (clone HUTS21) for 45 min at room temperature. Red blood cells were then lysed with ammonium chloride lysis buffer and washed. Samples were then analyzed FACS array (BD Bioscience). Appropriate isotype controls of the antibodies were also run.
Statistical analysis
SigmaPlot 10.0 (Systat Software, San Josa, CA) was used for all analysis. Chi-squared analysis was used for categorical analysis. One way ANOVA and one way ANOVA on ranks analysis were used to compare findings among the three groups: SIRS, sepsis, or normal controls. Statistical significance was set at p \ 0.05.
Results
Over the course of the study, 88 patients were enrolled. Ten healthy volunteer controls were also enrolled (Group 1). 35 patients exhibited SIRS with no evidence of infection (Group 2), whereas 53 of the patients had sepsis upon enrollment (Group 3). There was no significant difference between the three groups with respect to gender. Although both patient groups were slightly older than controls, there was no difference in age between patients with SIRS versus sepsis (54.5 versus 56.3 years; p = 0.9). Furthermore, there was no difference in APACHE II scores among SIRS and sepsis patients (16.8 versus 19.5; p = 0.07). Both patient groups had significantly higher WCC compared with controls, but there was no difference in WCC between SIRS and septic patients (12.5 ± 0.9 versus 14.4 ± 0.7 9 10 9 /L; p = 0.09) ( Table 1 ). All patients with sepsis were receiving antimicrobial therapy, and 11 (21%) were receiving vasoactive pressors at the time of the blood draw.
Both patient groups had significantly lower percentage as well as absolute number of circulating CD3
? lymphocytes when compared with controls. However, there was no significant difference between SIRS and sepsis patients with respect to percent or number of circulating CD3 ? lymphocyte populations (Table 2) .
Samples were analyzed for CD18 expression on CD3 ? T cells. CD18 was noted to be almost ubiquitously expressed on all CD3
? lymphocytes among normal controls (98.5%), SIRS (98.2%), or septic (97.9%) patients (p = 0.91) (Fig. 1) . This led to no significant difference in absolute number of circulating CD18
? CD3 ? lymphocytes between SIRS and sepsis patients (0.821 versus 0.819 9 10 9 /L; p = 0.95) ( Table 2) .
Next, samples were analyzed for the expression of CD29 on CD3
? lymphocytes. CD29 expression on CD3 ? lymphocytes was significantly different across all three groups. Normal controls had the greatest percent of CD3
? lymphocytes expressing CD29 (54.1%). Notably, septic patients had significantly greater percentage of CD29 ?-
CD3
? lymphocytes (35.5%) when compared to patients with SIRS (20.4%) (Fig. 2) . Assessing for absolute cell counts, both patient groups were noted to have lower numbers of CD29
? CD3
? lymphocytes compared to normal controls. Furthermore, patients with sepsis compared with SIRS had greater numbers of circulating CD29
? lymphocytes (0.294 versus 0.162 9 10 9 /L; p \ 0.05) ( Table 2) .
Of the septic patients, 21 had an abdominal source of sepsis compared with 32 patients who had a non-abdominal source of sepsis. We analyzed the CD29 expression on CD3
? Lymphoctytes with respect to abdominal versus non-abdominal sources of sepsis. Patients with abdominal sepsis had significantly elevated percentage of blood CD3
? lymphocytes expressing CD29 (41.7% ± 2.9 versus 29.5% ± 3.9; p = 0.014) (Fig. 3) . Accounting for absolute number of cells, patients with an abdominal source of sepsis had significantly higher numbers of circulating CD3
? CD29
? lymphocytes (0.36 ± 0.038 versus 0.24 ± 0.043 9 10 9 /L; p = 0.035).
Discussion
The morbidity and mortality following either severe tissue injury, as seen in the Systemic Inflammatory Response System (SIRS) or with severe infection (sepsis), remain dismally high [2] . This is often thought to be due to a dysregulation of the inflammatory and immune system [4] . SIRS and sepsis share many similar clinical characteristics, such as tachycardia, leukocytosis, and capillary leak. Indeed, many components of therapy are similar between both clinical entities, including large volume fluid Integrins are essential to normal T-cell functioning. T-lymphocytes use integrins to migrate in and out of lymph nodes and, following infection, to migrate into other tissues [14, 17, 18, 25] . Integrins are key to the immunological cross-talk between T cells and antigen-presenting cells. Much of the work on lymphocyte integrins relates to their function in animal models and T cells from normal humans or from patients with chronic non-acute diseases. There is a paucity of data pertaining to the effects of SIRS or sepsis on human lymphocyte T-cell integrin expression and no data regarding a differential expression between SIRS and sepsis. We have demonstrated here marked differences in lymphocyte integrin expression in two distinct critically ill conditions, SIRS and sepsis.
A robust leukocyte tissue influx has been associated with increased mortality in SIRS and sepsis, potentially from cell-mediated tissue destruction [26] . Increased integrin expression, specifically ICAM and b2, mediates an excessive neutrophil influx into tissues [27, 28] . b1 integrins mediate their effects on lymphocyte migration via, among others CXCR4-an important chemokine involved in lymphocyte migration [29, 30] . CXCR4 expression has been shown to be up-regulated upon lymphocytes from patients with sepsis [31] . Transmigration is the final and least well-understood step in lymphocyte homing cascade. It has recently been shown that lymphocytes can migrate directly through endothelial cells (transcellular). Both b1 and b2 integrins have been shown to be involved in this process via interactions with endothelial junction integrin ligands, such as JAM-B and JAM-A, respectively [32, 33] . Modulating the chemokine/integrin axis may offer a potential therapeutic target to modulate sufficient leukocyte infiltration to allow bacterial clearance while limiting tissue destruction [34] .
Integrin b2, CD18, is typically expressed on all lymphocytes [16, 25, 35] with the exception of certain rare immuno-compromised diseases, such as leukocyte 
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? lymphocytes in abdominal versus non-abdominal sepsis adhesion deficiency (LAD)-1 syndrome. From this disease, it has shown that the lack of CD18 causes adhesion and mobility deficiencies that result in multiple skin infections and slow wound healing [36] . Consistent with established data, we have shown that CD18 is ubiquitously expressed on all lymphocytes in the peripheral blood [15, 25] . The levels of lymphocyte CD18 expression were unchanged by the clinical circumstances with all groups displaying approximately 100% expression. Between healthy controls, SIRS or sepsis, or considering source of sepsis, CD18 expression does not display any significant difference. Integrin b1, CD29, is a protein encoded by the ITGB1 gene. It interacts with ligands VCAM-1 and MAdCAM-1 during adhesions and also interacts with collagen, fibronectin, and laminin [14, 17, 37] . Deficiency of CD29 is known to affect cellular migration in a variety of conditions [38] [39] [40] . Specifically, the Huts21 CD29 antibody represents activated integrin [41] . We herein demonstrate that patients with either critical condition, SIRS, or sepsis, displayed significantly lowered CD29 expression on peripheral lymphocytes, potentially a reflection of the immune dysfunction induced by critical illness. Compared to those with SIRS, a state of sterile inflammation, patients with sepsis have a greater need for a directed cellular response to a specific site of infection, requiring leukocyte transmigration from the vascular space to a focus of infection. The increased CD29 expression on lymphocytes of patients with sepsis would provide better endothelial adherence or trans-endothelial migration of T cells. Our finding of the lowered CD29 expression in patients with SIRS rather than sepsis would potentially fit this observation. Patients with sepsis have a greater need for cellular localization (transmigration) to the source of the infection [42] , rather than patients exhibiting SIRS, where there is no focal point of infection.
An intriguing finding in our results was the difference in peripheral blood T-cell CD29 expression between abdominal and non-abdominal sources of sepsis. Patients with abdominal sepsis displayed significantly lower CD29 expression compared to patients with non-abdominal sources of sepsis. There is a growing body of the literature suggestive of a compartmentalization effect with abdominal pathologies and inflammatory responses [9, 43, 44] . Akin to this work, we speculate that the abdominal cavity offers a containment and protective environment, attempting to limit the systemic nature of the insult. Stromberg et al. demonstrated that T-cell infiltration following gut injury and sepsis improves survival following sepsis [45] . It has been shown that lymphocytes play a vital role in mediating gut epithelial apoptosis in sepsis but not under normal conditions. However, the exact cause/effect of lymphocyte migration to the peritoneal cavity remains unclear. Clearly, the ability of lymphocytes to travel between tissues in patients with systemic evidence of infection and injury remains critical.
That said, this current work cannot address a possible cause and effect to our observations. It is often uncertain whether the illness leads to alteration of cellular functions, or whether the altered cellular function leads to the predisposition to critical illness and/or infection. These data support our hypothesis that a differential lymphocyte integrin expression exists between patients with generalized tissue destruction (SIRS) compared with patients needing a more active directed lymphocyte migration to a focus of infection (sepsis).
Conclusion
Sepsis and SIRS remain leading causes of death in ICU patients. Lymphocytes play a key role in the pathogenesis and progression of both entities. We have demonstrated clear differences in Integrin expression on T cells from two distinctively different critical conditions which often have overlapping clinical presentation. Understanding changes in lymphocyte integrin expression in each will allow for potential therapeutic targets, leading to better control over cellular migration and ultimately end-organ dysfunction seen in both condition. Furthermore, it may begin to explain why certain patients with SIRS progress to sepsis and ultimately septic shock and death.
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